{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T23:50:59Z","timestamp":1788565859485,"version":"build-2803163510"},"reference-count":20,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T00:00:00Z","timestamp":1654214400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cardiovasc. Med."],"abstract":"<jats:sec><jats:title>Background<\/jats:title><jats:p>Cardioversion (CV) for atrial fibrillation (AF) is common. We aimed to assess changes in QTc over time following electrical CV (ECV) for persistent AF, and to compare the benefit of using continuous Holter monitoring vs. conventional follow-up by ECG.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Prospective observational cohort study. We comprised 90 patients admitted to our center for elective ECV due to persistent AF who were prospectively enrolled from July 2017 to August 2018. All patients underwent 7-days Holter started prior to ECV. Baseline QTc was defined as median QTc during 1 h post ECV. The primary endpoint was QTc prolongation defined as QTc \u2265500 ms, or \u226510% increase (if baseline QTc was &amp;gt;480 ms). Conventional monitoring was defined as 2-h ECG post ECV.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>Mean age was 67 \u00b1 11 years and 61% were male. Median baseline QTc was 452 ms (IQ range: 431\u2013479 ms) as compared with a maximal median QTc of 474 ms (IQ range: 433\u2013527 ms; <jats:italic>p<\/jats:italic> &amp;lt;0.001 for the change in QTc from baseline). Peak median QTc occurred 44 h post ECV. The primary endpoint was met in 3 patients (3%) using conventional monitoring, compared with 39 new patients (43%) using Holter (<jats:italic>p<\/jats:italic> &amp;lt;0.001 for comparison). The Holter monitoring was superior to conventional monitoring in detecting clinically significant QTc prolongation (OR = 13; <jats:italic>p<\/jats:italic> &amp;lt;0.001).<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>ECV of patients with persistent AF was associated with increased transient risk of QTc prolongation in nearly half of the patients. Peak median QTc occurs during end of second day following ECV and prolonged ECG monitoring provides superior detection of significant QTc prolongation compared with conventional monitoring.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcvm.2022.881446","type":"journal-article","created":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T13:29:13Z","timestamp":1654262953000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":5,"title":["QTc Dynamics Following Cardioversion for Persistent Atrial Fibrillation"],"prefix":"10.3389","volume":"9","author":[{"given":"Arwa","family":"Younis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nofrat","family":"Nehoray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Glikson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Bodurian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eyal","family":"Nof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola Luigi","family":"Bragazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wojciech","family":"Zareba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Goldenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Beinart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2022,6,3]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1142","DOI":"10.1016\/j.amjcard.2013.05.063","article-title":"Liu X. Estimates of current and future incidence and prevalence of atrial fibrillation in the US adult population","volume":"112","author":"Colilla","year":"2013","journal-title":"Am J Cardiol."},{"key":"B2","doi-asserted-by":"publisher","first-page":"147R","DOI":"10.1016\/S0002-9149(99)00715-8","article-title":"Pharmacologic versus direct-current electrical cardioversion of atrial flutter and fibrillation","volume":"84","author":"Van Gelder","year":"1999","journal-title":"Am J Cardiol"},{"key":"B3","doi-asserted-by":"publisher","first-page":"396","DOI":"10.1016\/S0735-1097(99)00226-0","article-title":"Dell'Orto S, Roden DM. Exaggerated QT prolongation after cardioversion of atrial fibrillation","volume":"34","author":"Choy","year":"1999","journal-title":"J Am Coll Cardiol."},{"key":"B4","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/S1036-7314(05)80037-2","article-title":"Torsades de pointes following cardioversion: case history and literature review","volume":"16","author":"Spearritt","year":"2003","journal-title":"Aust Crit Care."},{"key":"B5","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1093\/europace\/eum270","article-title":"Electrocardiographic evidence of ventricular repolarization remodelling during atrial fibrillation","volume":"10","author":"Tan","year":"2008","journal-title":"Europace."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e199","DOI":"10.1161\/CIR.0000000000000041","article-title":"2014 AHA\/ACC\/HRS guideline for the management of patients with atrial fibrillation: a report of the American College of Cardiology\/American Heart Association Task Force on practice guidelines and the Heart Rhythm Society","volume":"130","author":"January","year":"2014","journal-title":"Circulation"},{"key":"B7","doi-asserted-by":"publisher","first-page":"2893","DOI":"10.1093\/eurheartj\/ehw210","article-title":"2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS","volume":"37","author":"Kirchhof","year":"2016","journal-title":"Eur Heart J."},{"key":"B8","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1056\/NEJMra032426","article-title":"Drug-induced prolongation of the QT interval","volume":"350","author":"Roden","year":"2004","journal-title":"N Engl J Med."},{"key":"B9","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1136\/hrt.76.5.422","article-title":"Accuracy of four automatic QT measurement techniques in cardiac patients and healthy subjects","volume":"76","author":"McLaughlin","year":"1996","journal-title":"Heart."},{"key":"B10","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1016\/S0002-9149(97)00927-2","article-title":"Agreement and reproducibility of automatic versus manual measurement of QT interval and QT dispersion","volume":"81","author":"Savelieva","year":"1998","journal-title":"Am J Cardiol."},{"key":"B11","doi-asserted-by":"publisher","first-page":"1719","DOI":"10.1185\/03007995.2013.840568","article-title":"QT interval prolongation and the risk of torsades de pointes: essentials for clinicians","volume":"29","author":"Trinkley","year":"2013","journal-title":"Curr Med Res Opin."},{"key":"B12","doi-asserted-by":"publisher","first-page":"1671","DOI":"10.1016\/S0002-9149(99)00178-2","article-title":"Prolonged QT interval and altered QT\/RR relation early after radiofrequency ablation of the atrioventricular junction","volume":"83","author":"Cellarier","year":"1999","journal-title":"Am J Cardiol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1002\/clc.4960170410","article-title":"Torsade de pointes complicating drug treatment of low-malignant forms of arrhythmia: four cases reports","volume":"17","author":"Faber","year":"1994","journal-title":"Clin Cardiol."},{"key":"B14","doi-asserted-by":"publisher","first-page":"1044","DOI":"10.1111\/j.1540-8159.1998.tb00150.x","article-title":"Electrocardiographic and clinical predictors of torsades de pointes induced by almokalant infusion in patients with chronic atrial fibrillation or flutter: a prospective study","volume":"21","author":"Houltz","year":"1998","journal-title":"Pacing Clin Electrophysiol."},{"key":"B15","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1111\/j.1540-8159.1993.tb01821.x","article-title":"Serum electrolytes and catecholamines after cardioversion from ventricular tachycardia and atrial fibrillation","volume":"16","author":"Salerno","year":"1993","journal-title":"Pacing Clin Electrophysiol."},{"key":"B16","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1046\/j.1460-9592.2003.00114.x","article-title":"Post-tachycardia QT prolongation: maladjustment of the QT interval to the normal heart rate","volume":"26","author":"Viskin","year":"2003","journal-title":"Pacing Clin Electrophysiol."},{"key":"B17","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1152\/physrev.00014.2006","article-title":"Arrhythmogenic ion-channel remodeling in the heart: heart failure, myocardial infarction, and atrial fibrillation","volume":"87","author":"Nattel","year":"2007","journal-title":"Physiol Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1016\/j.yjmcc.2009.08.013","article-title":"Cardiac strong inward rectifier potassium channels","volume":"48","author":"Anumonwo","year":"2010","journal-title":"J Mol Cell Cardiol."},{"key":"B19","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1093\/europace\/euu086","article-title":"Effect of beta-blockers on QT dynamics in the long QT syndrome: measuring the benefit","volume":"16","author":"Bennett","year":"2014","journal-title":"Europace."},{"key":"B20","doi-asserted-by":"publisher","first-page":"479","DOI":"10.1161\/CIRCOUTCOMES.113.000152","article-title":"Development and validation of a risk score to predict QT interval prolongation in hospitalized patients","volume":"6","author":"Tisdale","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes."}],"container-title":["Frontiers in Cardiovascular Medicine"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.881446\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,6,3]],"date-time":"2022-06-03T13:29:16Z","timestamp":1654262956000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcvm.2022.881446\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,3]]},"references-count":20,"alternative-id":["10.3389\/fcvm.2022.881446"],"URL":"https:\/\/doi.org\/10.3389\/fcvm.2022.881446","relation":{},"ISSN":["2297-055X"],"issn-type":[{"value":"2297-055X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,3]]},"article-number":"881446"}}